Description

Membral (memantine) Coated Tablets 10 mg. №30

Ingredients

Active ingredient: Memantine hydrochloride. Inactive ingredients: microcrystalline cellulose, colloidal silicon dioxide, talc, magnesium stearate, hypromellose, macrogol, titanium dioxide, iron oxide yellow.

Dosage

Recommended dosage: The usual starting dose is 5 mg once daily. The dose is then increased by 5 mg each week. The maximum recommended dose is 20 mg per day, taken in divided doses.

Indications

Membral (memantine) Coated Tablets are indicated for the treatment of moderate to severe Alzheimer’s disease.

Contraindications

Do not use Membral (memantine) Coated Tablets if you are allergic to memantine or any other ingredients in the product. Consult your healthcare provider before use if you have a history of seizures or severe kidney problems.

Directions

Take Membral (memantine) Coated Tablets exactly as prescribed by your healthcare provider. Swallow the tablets whole with water. Do not crush or chew the tablets.

Scientific Evidence

Memantine has shown efficacy in improving cognitive function and activities of daily living in patients with Alzheimer’s disease. Studies have demonstrated that memantine can help reduce symptoms of dementia by modulating glutamatergic neurotransmission in the brain. Research published in the Journal of Alzheimer’s Disease found that memantine treatment was associated with a slower decline in cognitive function compared to placebo.

Additional Information

Membral (memantine) Coated Tablets have a good safety profile with minimal side effects. Common side effects may include headache, constipation, and dizziness. It is important to follow the prescribed dosage and consult your healthcare provider if you experience any adverse reactions.

Memantine works by blocking the action of glutamate, a neurotransmitter involved in learning and memory. By regulating glutamate levels, memantine helps improve communication between nerve cells and prevent damage caused by excess glutamate.

Clinical trials have shown that memantine is well-tolerated and effective in managing symptoms of Alzheimer’s disease. A study published in the Journal of Clinical Psychopharmacology reported that memantine treatment was associated with significant improvements in cognitive function and global clinical status compared to placebo.